Article Details
Retrieved on: 2021-04-29 09:10:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company reported ($0.83) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.70) by ($0.13). Vir Biotechnology ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here